Dr Reddys Laboratories (RDY) Cash & Equivalents (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Cash & Equivalents of $164.0 million for Q1 2026, down 4.65% year-over-year from $172.0 million in Q1 2025, and down 4.65% quarter-over-quarter from $172.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Cash & Equivalents (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $164.0 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 4.65% year-over-year to $164.0 million; the TTM figure through Mar 2026 stood at $164.0 million (down 4.65% YoY), while the FY2026 annual figure was $164.0 million, down 4.65% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $164.0 million, down from $172.0 million in the prior quarter.
- The five-year high for Cash & Equivalents was $761.0 million in Q1 2023, with the low at $85.0 million in Q1 2024.
- The 5-year median for Cash & Equivalents is $196.0 million (2022), against an average of $365.0 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 288.27% in 2023, then slumped 88.83% in 2024.
- Dr Reddys Laboratories' Cash & Equivalents stood at $432.0 million in 2022, then jumped by 72.45% to $745.0 million in 2023, then plunged by 88.59% to $85.0 million in 2024, then surged by 102.35% to $172.0 million in 2025, then slipped by 4.65% to $164.0 million in 2026.
- Business Quant data shows RDY's Cash & Equivalents at $164.0 million in Q1 2026, $172.0 million in Q1 2025, and $85.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 164.00 Mn |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 511.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 164.00 Mn |
| Mar 31, 2025 | 172.00 Mn |
| Mar 31, 2024 | 85.00 Mn |
| Jun 30, 2023 | 745.00 Mn |
| Mar 31, 2023 | 761.00 Mn |
| Jun 30, 2022 | 432.00 Mn |
| Mar 31, 2022 | 196.00 Mn |
| Mar 31, 2021 | 203.00 Mn |
| Dec 31, 2020 | 291.00 Mn |
| Sep 30, 2020 | 357.00 Mn |
| Mar 31, 2020 | 27.00 Mn |
| Dec 31, 2019 | 280.00 Mn |
| Sep 30, 2019 | 427.00 Mn |
| Mar 31, 2019 | 32.00 Mn |
| Dec 31, 2018 | 359.00 Mn |
| Jun 30, 2018 | 249.00 Mn |
| Mar 31, 2018 | 344.00 Mn |
| Dec 31, 2017 | 344,000.00 Bn |
| Sep 30, 2017 | 263,000.00 Bn |
| Jun 17, 2017 | 226.00 |